Our leadership team

Mark Warne was appointed as Chief Executive of the Company on 2 July 2018. Mark, who joined deepmatter^® as a Non-Executive Director in September 2015, also served as its Executive Chairman between April 2017 and July 2018. Mark is widely recognised in the UK and international life sciences sector, having spent almost ten years at IP Group plc, a leading intellectual property commercialisation company, where he led the Healthcare team. He managed a portfolio of £330m of net assets in 2016/17 and represented IP Group on the boards of both listed and private companies. In 2018, concurrent with the integration of Touchstone Innovations into IP Group, Mark became a Partner in the Life Sciences division. He joined IP Group from pre-clinical drug discovery CRO Exelgen, where he was Managing Director. Mark spent eight years at Exelgen (formerly Tripos Discovery Research) where he also held positions in licensing and strategic affairs, project management and research. He has a PhD in Computational Chemistry, an MSc in Colloid Science and a BSc in Chemistry, all from the University of Bristol. Mark is a Chartered Chemist and member of the Royal Society of Chemistry. He serves as a Non-Executive Director on the board of Ixico Plc and as an advisor for Angelini Ventures.

Appointed June 2021.

Over 25 years’ experience in the life sciences technology sector spanning company formation, business development and investment. Previous investor roles at Bioscience Managers PTY and IP Group plc and business development roles at Abcodia and Quotient Sciences, a clinical drug development CRO.

PhD, Molecular Virology, BSc (Hons) First Class, Microbiology and Biotechnology and MBA with distinction.

Joined the management team as Chief of Staff in early 2021 having being our Executive Assistant since June 2019. Jenny previously held positions at IP Group plc and Reed Specialist Recruitment managing all aspects of business administration in SMEs.

Meryem Guersu leads DeepMatter’s Customer Success Team. Meryem’s team are first line support for software roll outs, technical and trial support. Meryem joined us from Foundation Medicine where she  was the Clinical Program Lead working with Academic and BioPharma partners. As an early employee of Foundation Medicine Penzberg, she helped build the operating procedures and customer services from the ground up.

She previously worked for Roche Diagnostics  and Mercedes-Benz and has two BSc degrees in Chemistry and Chemical Engineering from the Istanbul Technical University and an MSc in Chemical Engineering from the Technical University of Munich.

Thomas is the founder of our subsidiary ChemIntelligence SAS, based in Lyon, France, heads Group Technology including Product & Development and acts as a Scientific Advocate for the Company. He previously worked as a chemistry researcher at Solvay and holds a PhD in chemistry. Thomas has had considerable success in the setup of ChemAssistant®, from designing architecture to building the product.